We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LNTH Lantheus Holdings Inc

2.17 (3.03%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,164,364
Bid Price 72.59
Ask Price 75.00
News -
Day High 74.54


52 Week Range


Day Low 71.00
Share Name Share Symbol Market Stock Type
Lantheus Holdings Inc LNTH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
2.17 3.03% 73.79 18:53:27
Open Price Low Price High Price Close Price Previous Close
71.40 71.00 74.54 73.79 71.62
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
19,313 1,164,364 US$ 73.57 US$ 85,662,866 - 47.46 - 100.48
Last Trade Type Quantity Price Currency
18:58:34 1 US$ 74.50 USD

Lantheus (LNTH) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Lantheus Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.05B 68.49M - 935.06M 28.07M 0.41 180.06
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lantheus News

Date Time Source News Article
11/20/202315:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/16/202312:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/15/202315:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/15/202315:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/13/202313:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/08/202307:00GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare..
11/02/202306:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202306:44Edgar (US Regulatory)Form 8-K - Current report
11/02/202306:00GlobeNewswire Inc.Lantheus Reports Third Quarter 2023 Financial Results
10/19/202307:00GlobeNewswire Inc.Lantheus to Host Third Quarter 2023 Earnings Conference Call..
10/13/202316:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No LNTH Message Board. Create One! See More Posts on LNTH Message Board See More Message Board Posts

Historical LNTH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week68.6074.5468.0070.51674,3955.197.57%
1 Month63.2974.5461.6167.14681,73510.5016.59%
3 Months66.3676.9959.8567.21971,1547.4311.2%
6 Months87.2794.4759.8573.98989,361-13.48-15.45%
1 Year62.61100.4847.4672.181,039,24511.1817.86%
3 Years13.32100.4813.0157.41896,15660.47453.98%
5 Years19.00100.488.6747.98701,89154.79288.37%

Lantheus Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |